Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2023 | Story Lunga Luthuli | Photo Supplied
Imtiaz Sooliman
Dr Imtiaz Sooliman, founder of the Gift of the Givers Foundation, speaks at a University of the Free State Brown Bag Lunch, sharing insights on how postgraduate education can empower individuals to bring hope and change to those around them.

The University of the Free State (UFS) Centre for Graduate Support (CGS) recently hosted Dr Imtiaz Sooliman, founder of the Gift of the Givers Foundation, at a CGS Brown Bag Lunch. The Brown Bag Lunches are a series of informal talks aimed at providing guidance and inspiration to postgraduate students.  

The event served as a platform for Dr Sooliman to share his insights into how pursuing a postgraduate degree can empower individuals to bring hope and change to those around them.

He said his talk was inspired by his own journey: “After receiving a message from my spiritual leader in Istanbul, Turkey, at the age of just 30, I immediately heeded the calling and established the Gift of the Givers Foundation.”

He emphasised that success and progress are not possible without faith and spirituality, and that these were motivating factors in his work. “The foundation works to unite people with a common vision to make a real difference by serving mankind for the greater good.”

Dr Sooliman shared many of his experiences and insights with the audience. He said the foundation has provided critical aid to many disaster-stricken regions and has extended its assistance to the most vulnerable populations worldwide.

Creating hope 

The Gift of the Givers Foundation also provides support to the UFS No Student Hungry Programme, which delivers food parcels to needy students on the UFS’s three campuses.  

Dr Sooliman’s efforts have helped the foundation make a real and telling difference in the lives of people from all classes, political affiliations, and geographical locations

He encouraged students and academics in the audience to “view your pursuit of higher education as a means to gain knowledge, but also as a tool to cultivate empathy, resilience, and a sense of purpose”.

Event organisers said the University of the Free State continues to promote education and community engagement, and Dr Sooliman’s visit served as a beacon of inspiration for students and academics alike.

Dr Danila Wessels, Assistant Director at the Centre for Graduate Support, said, “Inviting Dr Imtiaz Sooliman to our Brown Bag Lunch event was a deliberate choice driven by our commitment to broadening the vision of UFS postgraduate students. We believe that postgraduate studies can serve as a powerful impetus for bringing hope to people, and Dr Sooliman's inspirational journey perfectly exemplifies this." 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept